Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells
- PMID: 11522656
Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells
Abstract
RRR-alpha-tocopherol succinate (vitamin E succinate, VES) is a potent, selective apoptotic agent for cancer cells but not normal cells. VES has been shown to inhibit the growth of a wide variety of tumor cells in cell culture and animal models. Studies addressing mechanisms of action of VES-induced apoptosis have identified transforming growth factor-beta, Fas/CD95-APO-1, and mitogen-activated protein kinase (MAPK) signaling pathway involvement. Here we show that MAPKs, the extracellular signal-regulated kinases (ERK), and the stress-activated protein kinases, c-Jun NH2-terminal kinases (JNK), but not p38, are critical mediators in VES-induced apoptosis of human breast cancer MDA-MB-435 cells. VES activates ERK1/2 and JNK both in level and duration of kinase activity. Expression of dominant negative mutants of ERK1, MAPK/ERK activator-1, or JNK1 but not p38 blocked phosphorylation of the substrate glutathione S-transferase-c-Jun and inhibited VES-induced apoptosis. Increased phosphorylation and transactivation activity of nuclear transcription factors c-Jun, ATF-2, and Elk-1 are observed after VES treatments; however, only c-Jun and ATF-2 appear to be involved in VES-induced apoptosis based on antisense blockage experiments. Collectively, these results imply a critical role for ERK1 and JNK1 but not p38 in VES-induced apoptosis of human MDA-MB-435 breast cancer cells.
Similar articles
-
RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria.Cancer Res. 2003 May 15;63(10):2483-91. Cancer Res. 2003. PMID: 12750270
-
RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation.Cell Growth Differ. 2001 Sep;12(9):471-80. Cell Growth Differ. 2001. PMID: 11571230
-
Signal transduction and the Ets family of transcription factors.Oncogene. 2000 Dec 18;19(55):6503-13. doi: 10.1038/sj.onc.1204036. Oncogene. 2000. PMID: 11175366 Review.
-
From receptors to stress-activated MAP kinases.Oncogene. 1999 Nov 1;18(45):6087-93. doi: 10.1038/sj.onc.1203129. Oncogene. 1999. PMID: 10557099 Review.
-
RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.Mol Carcinog. 1998 Aug;22(4):247-57. Mol Carcinog. 1998. PMID: 9726817
Cited by
-
Omilancor mitigates the senescence of nucleus pulposus cells induced by DDP through targeting MAP2K6.Aging (Albany NY). 2024 Mar 20;16(6):5050-5064. doi: 10.18632/aging.205588. Epub 2024 Mar 20. Aging (Albany NY). 2024. PMID: 38517363 Free PMC article.
-
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity.ACS Omega. 2021 Dec 22;7(1):875-899. doi: 10.1021/acsomega.1c05519. eCollection 2022 Jan 11. ACS Omega. 2021. PMID: 35036753 Free PMC article.
-
Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers.J Pers Med. 2021 Feb 2;11(2):92. doi: 10.3390/jpm11020092. J Pers Med. 2021. PMID: 33540693 Free PMC article. Review.
-
Targeting ERK-Hippo Interplay in Cancer Therapy.Int J Mol Sci. 2020 May 3;21(9):3236. doi: 10.3390/ijms21093236. Int J Mol Sci. 2020. PMID: 32375238 Free PMC article. Review.
-
Transferrin/α-tocopherol modified poly(amidoamine) dendrimers for improved tumor targeting and anticancer activity of paclitaxel.Nanomedicine (Lond). 2019 Dec;14(24):3159-3176. doi: 10.2217/nnm-2019-0128. Nanomedicine (Lond). 2019. PMID: 31855118 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous